dc.contributor.author | Yazici, H | |
dc.contributor.author | Ozbakir, F | |
dc.contributor.author | Hamuryudan, V | |
dc.contributor.author | Celik, A | |
dc.contributor.author | Yurdakul, S | |
dc.contributor.author | Fresko, I | |
dc.contributor.author | Ugurlu, S | |
dc.date.accessioned | 2021-03-03T18:05:12Z | |
dc.date.available | 2021-03-03T18:05:12Z | |
dc.date.issued | 2005 | |
dc.identifier.citation | Fresko I., Ugurlu S., Ozbakir F., Celik A., Yurdakul S., Hamuryudan V., Yazici H., "Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behcet's syndrome", CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, cilt.23, sa.4, 2005 | |
dc.identifier.issn | 0392-856X | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_4d24120c-0273-440b-b19e-b3b0b6566d8e | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/55188 | |
dc.description.abstract | Objectives. Anti-Saccharomyces cerevisiae antibodies (ASCA) are found in 50-60% of patients with Crohns disease. Increased as well as normal levels have been reported in Behcet's syndrome (BS). We reassessed the level of IgG and IgA ASCA antibodies in BS and in a group of diseased and healthy Controls. | |
dc.language.iso | eng | |
dc.subject | İmmünoloji ve Romatoloji | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ROMATOLOJİ | |
dc.title | Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behcet's syndrome | |
dc.type | Makale | |
dc.relation.journal | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | |
dc.contributor.department | , , | |
dc.identifier.volume | 23 | |
dc.identifier.issue | 4 | |
dc.contributor.firstauthorID | 175533 | |